2.820USD+6.42%Mkt Cap: 970.30M USDP/E: 47.75Last update: 2026-05-26
GoodRx Holdings, Inc., together with its subsidiaries, offers information and tools that enable consumers to compare prices and save on their prescription drug purchases in the United States. The company operates a price…
Industry Peers
Health Information Services25.85BUSDP/E 29.1
11.66BUSDP/E 78.1
8.39BUSD—
7.49BSEKP/E 33.5
7.35BUSDP/E 35.7
5.05BTRYP/E 27.0
4.13BUSD—
3.79BUSDP/E 29.5
Indicators:|
Key Statistics
Company
Market Cap970.30M USD
Enterprise Value1.17B USD
Revenue (TTM)787.89M USD
Gross Profit739.26M USD
Net Income (TTM)30.44M USD
Revenue/Share2.273 USD
Last Price2.820 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees697
CountryUS
SectorHealthcare
IndustryHealth Information Services
ISIN—
Valuation
P/E (Trailing)47.75
P/E (Forward)7.13
PEG—
EV/EBITDA10.72
EV/Revenue1.49
P/S1.10
P/B1.42
EPS (TTM)0.06
EPS (Forward)0.36
52W Range
1.77026% of range5.810
52W High5.810 USD
52W Low1.770 USD
Profitability
Gross Margin92.77%
Oper. Margin7.22%
EBITDA Margin13.89%
Profit Margin3.82%
ROE4.94%
ROA2.17%
Growth
Revenue Growth-4.40%
Earnings Growth-88.20%
Cash Flow & Leverage
Operating CF167.90M USD
CapEx (TTM)74.02M USD
FCF Margin10.74%
FCF Yield8.72%
Net Debt305.64M USD
Net Debt/EBITDA2.79
Balance Sheet
Debt/Equity0.88
Current Ratio1.47
Quick Ratio0.56
Book Value/Sh1.807 USD
Cash/Share0.6960 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating2.5 (Hold)
Target (Mean)3.181 USD
Target Range2.250 USD – 4.000 USD
# Analysts13
Ownership
Shares Out.104.71M
Float91.38M
Insiders13.06%
Institutions56.52%
Short Interest
Short Ratio6.0d
Short % Float8.16%
Short % Out.2.25%
Shares Short7.62M
Short (prev mo.)8.69M
Technical
SMA 502.306 (+22.3%)
SMA 2003.001 (-6.0%)
Beta1.55
S&P 52W Chg28.31%
Avg Vol (30d)1.65M
Avg Vol (10d)1.60M
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—